Frankfurt - Delayed Quote EUR
Biovica International AB (publ) (9II.F)
0.0504
0.0000
(0.00%)
At close: May 19 at 8:11:52 AM GMT+2
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Anders Rylander | President, CEO & Director | -- | -- | 1970 |
| Mr. Anders Moren | Chief Financial Officer | -- | -- | 1965 |
| Ms. Hanna Ritzén | Chief Operating Officer | -- | -- | 1979 |
| Mr. Henrik Winther D.V.M., Ph.D. | Senior Vice President of Business Development | -- | -- | 1966 |
| Mr. Hector Tamburini | Head of US Laboratory Operations, Regulatory & Quality | -- | -- | 1962 |
Biovica International AB (publ)
Dag HammarskjOelds vAeg 54B
Uppsala Science Park
Uppsala, 752 37
Sweden
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 26
Description
Biovica International AB (publ), a biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America. It primarily focuses on breast cancer. The company develops DiviTum TKa, a blood-based biomarker assay that measures thymidine kinase activity, which is correlated with cell proliferation. It serves cancer institutes, pharmaceutical companies, and collaborative groups. Biovica International AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.
Corporate Governance
Biovica International AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
June 18, 2025 at 10:59 AM UTC
Biovica International AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
PHGN.BE Pharming Group
0.8505
+2.72%
ACTI.ST Active Biotech AB (publ)
0.1172
-6.09%
ONCO.ST Oncopeptides AB (publ)
1.9980
-0.10%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2680
+5.10%
PHAR Pharming Group N.V.
9.31
-5.67%
ZEAL.CO Zealand Pharma A/S
416.00
-0.26%
RCKT Rocket Pharmaceuticals, Inc.
6.45
-0.77%
PLX Protalix BioTherapeutics, Inc.
1.6800
+0.60%
IVVD Invivyd, Inc.
0.7756
-0.14%
IBRX ImmunityBio, Inc.
2.8000
-1.41%